The report covers forecast and analysis for the Optogenetics Actuators and Sensors market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Optogenetics Actuators and Sensors market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Optogenetics Actuators and Sensors market on a global level. In order to give the users of this report a comprehensive view on the Optogenetics Actuators and Sensors market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product type, disease type, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
According to the report, global demand for Optogenetics Actuators and Sensors market was valued at approximately USD 511.88 million in 2018, and is expected to generate revenue of around USD 567.38 million by end of 2025, growing at a CAGR of around 1.53% between 2019 and 2025.
Optogenetics is a type of technique used to regulate neuronal function by optically-activated proteins. It is one of the latest biomedical innovation that provides treatment options for incurable diseases such as Parkinson's disease, Alzheimer's disease and retinal diseases. Optogenetic techniques allow a high degree of spatial, temporal, and neurochemical accuracy to activate or inhibit specific neurons. In this technique, algae species are taken from the gene that codes for light-sensitive protein. Actually, this protein acts as an ion channel that opens or closes in response to specific light wavelengths. The gene that codes for this protein is inserted into the brain's unique neuron and expressed to generate this protein that is light sensitive. The neural signal is conducted on flashing light on specific neural cells. This approach can be used for monitoring neuron activity and understanding the role of cellular brain cells.
The study provides a decisive view on the Optogenetics Actuators and Sensors market by segmenting the market based on product type, disease type, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on product type, the market is segmented into actuators and sensors. Actuators are estimated to account for the largest share of revenue due to their increased use in neuroscience and ophthalmology-related investigations Sensors are expected to grow at the fastest rate in the coming years due to technological advances in optogenetics.
Based on disease type, the market is segmented into Retinal Disorders, Parkinson’s Disease, Anxiety & Depression, Autism, Schizophrenia and Others. Due to increased use of optogenetic actuators and sensors in disease-oriented research, retinal disorders dominate to be the largest share-holders. It is also predicted that the incidence of various retinal and psychiatric disorders will increase the segment.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America lead the market due to government support, extensive research, substantial local presence of players, and well-established Asia Pacific healthcare framework is expected to show the fastest development over the forecast period due to progressive industrialization and favorable government support.
Factors accountable for the development of the optogenetics actuators & sensors market are rising the burden of neurological disorders and retinal disease, rapid development and optogenetics research, and government funding such as monetary support for this field development. Optogenetics enables us to know which biochemical and physiological pathway works due to specific diseases, which can help find treatment for specific diseases by flashing blue light on specific neural cells. Age-related macular degeneration in industrialized countries is the primary cause of visual impairment. Alzheimer's disease is another possible field where optogenetics could provide a mechanism to effective care. There were an estimated 46.5 million Alzheimer's disease patients worldwide, according to the World Alzheimer Report in 2016.
Key players within global Optogenetics Actuators and Sensors market include Addgene, AGTC, Bruker, Circuit Therapeutics, Inc., Coherent, Inc, Elliot Scientific Ltd, Gensight Biologics, Merck KGaA, Noldus Information Technology, Prizmatix, Scientifica (Judges Scientific Plc Company), Shanghai Laser & Optics Century Co., Ltd. (SLOC), The Jackson Laboratory and Thorlabs, Inc. amongst others.
The report segments global Optogenetics Actuators and Sensors market as follows:
Global Optogenetics Actuators and Sensors Market: Product type Segment Analysis
Global Optogenetics Actuators and Sensors Market: Distribution Channel Segment Analysis
Global Optogenetics Actuators and Sensors Market: Regional Segment Analysis
According to the report, global demand for Optogenetics Actuators and Sensors market was valued at approximately USD 511.88 million in 2018, and is expected to generate revenue of around USD 567.38 million by end of 2025, growing at a CAGR of around 1.53% between 2019 and 2025.
Optogenetics is a type of technique used to regulate neuronal function by optically-activated proteins. It is one of the latest biomedical innovation that provides treatment options for incurable diseases such as Parkinson's disease, Alzheimer's disease and retinal diseases. Optogenetic techniques allow a high degree of spatial, temporal, and neurochemical accuracy to activate or inhibit specific neurons. In this technique, algae species are taken from the gene that codes for light-sensitive protein. Actually, this protein acts as an ion channel that opens or closes in response to specific light wavelengths. The gene that codes for this protein is inserted into the brain's unique neuron and expressed to generate this protein that is light sensitive. The neural signal is conducted on flashing light on specific neural cells. This approach can be used for monitoring neuron activity and understanding the role of cellular brain cells.
The study provides a decisive view on the Optogenetics Actuators and Sensors market by segmenting the market based on product type, disease type, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on product type, the market is segmented into actuators and sensors. Actuators are estimated to account for the largest share of revenue due to their increased use in neuroscience and ophthalmology-related investigations Sensors are expected to grow at the fastest rate in the coming years due to technological advances in optogenetics.
Based on disease type, the market is segmented into Retinal Disorders, Parkinson’s Disease, Anxiety & Depression, Autism, Schizophrenia and Others. Due to increased use of optogenetic actuators and sensors in disease-oriented research, retinal disorders dominate to be the largest share-holders. It is also predicted that the incidence of various retinal and psychiatric disorders will increase the segment.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America lead the market due to government support, extensive research, substantial local presence of players, and well-established Asia Pacific healthcare framework is expected to show the fastest development over the forecast period due to progressive industrialization and favorable government support.
Factors accountable for the development of the optogenetics actuators & sensors market are rising the burden of neurological disorders and retinal disease, rapid development and optogenetics research, and government funding such as monetary support for this field development. Optogenetics enables us to know which biochemical and physiological pathway works due to specific diseases, which can help find treatment for specific diseases by flashing blue light on specific neural cells. Age-related macular degeneration in industrialized countries is the primary cause of visual impairment. Alzheimer's disease is another possible field where optogenetics could provide a mechanism to effective care. There were an estimated 46.5 million Alzheimer's disease patients worldwide, according to the World Alzheimer Report in 2016.
Key players within global Optogenetics Actuators and Sensors market include Addgene, AGTC, Bruker, Circuit Therapeutics, Inc., Coherent, Inc, Elliot Scientific Ltd, Gensight Biologics, Merck KGaA, Noldus Information Technology, Prizmatix, Scientifica (Judges Scientific Plc Company), Shanghai Laser & Optics Century Co., Ltd. (SLOC), The Jackson Laboratory and Thorlabs, Inc. amongst others.
The report segments global Optogenetics Actuators and Sensors market as follows:
Global Optogenetics Actuators and Sensors Market: Product type Segment Analysis
- Actuators
- Channelrhodopsin
- Halorhodopsin Biochip
- Archaerhodopsin
- Sensors
- Genetically Encoded Calcium Indicators
- Voltage-Sensitive Fluorescent Proteins
- pH Sensors
- Retinal Disorders
- Parkinson’s Disease
- Anxiety & Depression
- Autism
- Schizophrenia
- Others
Global Optogenetics Actuators and Sensors Market: Distribution Channel Segment Analysis
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Optogenetics Actuators and Sensors Market: Regional Segment Analysis
- North America
- U.S.
- Europe
- UK
- France
- Germany
- Asia Pacific
- China
- Japan
- India
- Latin America
- Brazil
- Middle East and Africa
Table of Contents
- Chapter 1. Preface
- 1.1. Report Description and Scope
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
- Chapter 2. Executive Summary
- 2.1. Optogenetics Actuators and Sensors Market, 2016-2025 (USD Million)
- 2.2. Optogenetics Actuators and Sensors Market: Snapshot
- Chapter 3. Optogenetics Actuators and Sensors Market - Industry Analysis
- 3.1. Optogenetics Actuators and Sensors Market: Market Dynamics
- 3.2. Market Drivers
- 3.2.1. Driver 1
- 3.2.2. Driver 2
- 3.3. Restraints
- 3.3.1. Restraint 1
- 3.3.2. Restraint 2
- 3.4. Opportunity
- 3.4.1. Government funding and support
- 3.5. Porter's Five Forces Analysis
- 3.6. Market Attractiveness Analysis
- 3.6.1. Market attractiveness analysis By Product
- 3.6.2. Market attractiveness analysis By Disease type
- 3.6.3. Market attractiveness analysis By Distribution Channel
- 3.6.4. Market attractiveness analysis By Region
- Chapter 4. Optogenetics Actuators and Sensors Market- Competitive Landscape
- 4.1. Company market share analysis
- 4.1.1. Global Optogenetics Actuators and Sensors Market: company market share, 2018
- 4.2. Strategic development
- 4.2.1. Acquisitions & mergers
- 4.2.2. New Product launches
- 4.2.3. Agreements, partnerships, collaborations and joint ventures
- 4.2.4. Research and development and Regional expansion
- 4.3. Price trend analysis
- 4.1. Company market share analysis
- Chapter 5. Global Optogenetics Actuators and Sensors Market - Product type Analysis
- 5.1. Global Optogenetics Actuators and Sensors Market overview: By Product type
- 5.1.1. Global Optogenetics Actuators and Sensors Market share, By Product,2018 and 2025
- 5.2. Actuators
- 5.2.1. Global Optogenetics Actuators and Sensors Market By Actuators, 2016-2025 (USD Million)
- 5.3. Channelrhodopsin
- 5.3.1. Global Optogenetics Actuators and Sensors Market By Channelrhodopsin, 2016-2025 (USD Million)
- 5.4. Halorhodopsin Biochip
- 5.4.1. Global Optogenetics Actuators and Sensors Market By Halorhodopsin Biochip, 2016-2025 (USD Million)
- 5.5. Archaerhodopsin
- 5.5.1. Global Optogenetics Actuators and Sensors Market By Archaerhodopsin, 2016-2025 (USD Million)
- 5.6. Sensors
- 5.6.1. Global Optogenetics Actuators and Sensors Market By Sensors, 2016-2025 (USD Million)
- 5.7. Genetically Encoded Calcium Indicators
- 5.7.1. Global Optogenetics Actuators and Sensors Market By Genetically Encoded Calcium Indicators, 2016-2025 (USD Million)
- 5.8. Voltage-Sensitive Fluorescent Proteins
- 5.8.1. Global Optogenetics Actuators and Sensors Market By Voltage-Sensitive Fluorescent Proteins, 2016-2025 (USD Million)
- 5.9. pH Sensors
- 5.9.1. Global Optogenetics Actuators and Sensors Market By pH Sensors, 2016-2025 (USD Million)
- 5.1. Global Optogenetics Actuators and Sensors Market overview: By Product type
- Chapter 6. Global Optogenetics Actuators and Sensors Market -Disease type Analysis
- 6.1. Global Optogenetics Actuators and Sensors Market overview: By Disease type
- 6.1.1. Global Optogenetics Actuators and Sensors Market share, By Disease type, 2018 and 2025
- 6.2. Retinal Disorders
- 6.2.1. Global Optogenetics Actuators and Sensors Market By Retinal Disorders, 2016-2025 (USD Million)
- 6.3. Parkinson's Disease
- 6.3.1. Global Optogenetics Actuators and Sensors Market By Parkinson's Disease, 2016-2025 (USD Million)
- 6.4. Anxiety & Depression
- 6.4.1. Global Optogenetics Actuators and Sensors Market By Anxiety & Depression, 2016-2025 (USD Million)
- 6.5. Autism
- 6.5.1. Global Optogenetics Actuators and Sensors Market By Autism, 2016-2025 (USD Million)
- 6.6. Schizophrenia
- 6.6.1. Global Optogenetics Actuators and Sensors Market By Schizophrenia, 2016-2025 (USD Million)
- 6.1. Global Optogenetics Actuators and Sensors Market overview: By Disease type
- Chapter 7. Global Optogenetics Actuators and Sensors Market -Distribution Channel Analysis
- 7.1. Global Optogenetics Actuators and Sensors Market overview: By Distribution Channel
- 7.1.1. Global Optogenetics Actuators and Sensors Market share, By Distribution Channel, 2018 and 2025
- 7.2. Hospital Pharmacies
- 7.2.1. Global Optogenetics Actuators and Sensors Market By Hospital Pharmacies, 2016-2025 (USD Million)
- 7.3. Retail Pharmacies
- 7.3.1. Global Optogenetics Actuators and Sensors Market By Retail Pharmacies, 2016-2025 (USD Million)
- 7.4. Others
- 7.4.1. Global Optogenetics Actuators and Sensors Market By others, 2016-2025 (USD Million)
- 7.1. Global Optogenetics Actuators and Sensors Market overview: By Distribution Channel
- Chapter 8. Global Optogenetics Actuators and Sensors Market - Regional Analysis
- 8.1. Global Optogenetics Actuators and Sensors Market overview: By Region
- 8.1.1. Global Optogenetics Actuators and Sensors Market share, By Region, 2018 and 2025
- 8.2. North America
- 8.2.1. North America Optogenetics Actuators and Sensors Market, 2016-2025 (USD Million)
- 8.2.2. North America Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.2.3. North America Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.2.4. North America Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.2.5. The U.S.
- 8.2.5.1. The U.S.Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.2.5.2. The U.S.Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.2.5.3. The U.S.Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.2.6. Rest of North America
- 8.2.6.1. Rest of North America Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.2.6.2. Rest of North America Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.2.6.3. Rest of North America Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.3. Europe
- 8.3.1. EuropeOptogenetics Actuators and Sensors Market 2016-2025 (USD Million)
- 8.3.2. Europe Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.3.3. Europe Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.3.4. Europe Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.3.5. UK
- 8.3.5.1. U.K.Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.3.5.2. U.K.Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.3.5.3. U.K. Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.3.6. France
- 8.3.6.1. France Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.3.6.2. France Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.3.6.3. France Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.3.7. Germany
- 8.3.7.1. Germany Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.3.7.2. Germany Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.3.7.3. Germany Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.3.8. Rest of Europe
- 8.3.8.1. Rest of EuropeOptogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.3.8.2. Rest of EuropeOptogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.3.8.3. Rest of Europe Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.4. Asia Pacific
- 8.4.1. Asia Pacific Optogenetics Actuators and Sensors Market, 2016-2025 (USD Million)
- 8.4.2. Asia Pacific Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.4.3. Asia Pacific Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.4.4. Asia Pacific Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.4.5. China
- 8.4.5.1. China Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.4.5.2. China Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.4.5.3. China Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.4.6. Japan
- 8.4.6.1. Japan Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.4.6.2. Japan Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.4.6.3. Japan Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.4.7. India
- 8.4.7.1. India Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.4.7.2. India Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.4.7.3. India Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.4.8. Rest of Asia Pacific
- 8.4.8.1. Rest of Asia Pacific Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.4.8.2. Rest of Asia Pacific Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.4.8.3. Rest of Asia Pacific Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.5. Latin America
- 8.5.1. Latin America Optogenetics Actuators and Sensors Market, 2016-2025 (USD Million)
- 8.5.2. Latin America Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.5.3. Latin America Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.5.4. Latin America Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.5.5. Brazil
- 8.5.5.1. Brazil Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.5.5.2. Brazil Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.5.5.3. Brazil Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.5.6. Rest of Latin America
- 8.5.6.1. Rest of Latin America Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.5.6.2. Rest of Latin America Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.5.6.3. Rest of Latin America Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.6. The Middle East and Africa
- 8.6.1. The Middle East and Africa Optogenetics Actuators and Sensors Market, 2016-2025 (USD Million)
- 8.6.2. The Middle East and Africa Optogenetics Actuators and Sensors Market revenue, By Product,2016-2025 (USD Million)
- 8.6.3. The Middle East and Africa Optogenetics Actuators and Sensors Market revenue, By Disease type, 2016-2025 (USD Million)
- 8.6.4. The Middle East and Africa Optogenetics Actuators and Sensors Market revenue, By Distribution Channel, 2016-2025 (USD Million)
- 8.1. Global Optogenetics Actuators and Sensors Market overview: By Region
- Chapter 9. Company Profiles
- 9.1. Addgene
- 9.1.1. Overview
- 9.1.2. Financials
- 9.1.3. Product Portfolio
- 9.1.4. Business Strategy
- 9.1.5. Recent Developments
- 9.2. AGTC
- 9.2.1. Overview
- 9.2.2. Financials
- 9.2.3. Product Portfolio
- 9.2.4. Business Strategy
- 9.2.5. Recent Developments
- 9.3. Bruker
- 9.3.1. Overview
- 9.3.2. Financials
- 9.3.3. Product Portfolio
- 9.3.4. Business Strategy
- 9.3.5. Recent Developments
- 9.4. Circuit Therapeutics
- 9.4.1. Overview
- 9.4.2. Financials
- 9.4.3. Product Portfolio
- 9.4.4. Business Strategy
- 9.4.5. Recent Developments
- 9.5. Coherent, Inc
- 9.5.1. Overview
- 9.5.2. Financials
- 9.5.3. Product Portfolio
- 9.5.4. Business Strategy
- 9.5.5. Recent Development
- 9.6. Elliot Scientific Ltd
- 9.6.1. Overview
- 9.6.2. Financials
- 9.6.3. Product Portfolio
- 9.6.4. Business Strategy
- 9.6.5. Recent Development
- 9.7. Gensight Biologics
- 9.7.1. Overview
- 9.7.2. Financials
- 9.7.3. Product Portfolio
- 9.7.4. Business Strategy
- 9.7.5. Recent Development
- 9.8. Merck KGaA
- 9.8.1. Overview
- 9.8.2. Financials
- 9.8.3. Product Portfolio
- 9.8.4. Business Strategy
- 9.8.5. Recent Development
- 9.9. Noldus Information Technology
- 9.9.1. Overview
- 9.9.2. Financials
- 9.9.3. Product Portfolio
- 9.9.4. Business Strategy
- 9.9.5. Recent Development
- 9.10. Prizmatix
- 9.10.1. Overview
- 9.10.2. Financials
- 9.10.3. Product Portfolio
- 9.10.4. Business Strategy
- 9.10.5. Recent Development
- 9.1. Addgene
